Commission authorises first combined COVID-19 and influenza vaccine for people 50 years and older
22 April 2026 by Wendy WINN (DG SANTE, European Commission)The Commission has published on Union Register of medicinal products the decision granting EU marketing authorisation for mCombriax, an mRNA vaccine to protect people aged 50 years and older against COVID-19 and seasonal influenza. Most cases of COVID-19 and influenza are mild or moderate, but...